Foster common approaches between People’s Republic of China and the European Union on Personalised Medicine research, development, innovation and policies
We are glad to inform you that three of IC2PerMed's public reports are now available! These reports [...]
Participation is FREE. Register to save Your Spot ! Cancer is a devastating disease that kills hundreds [...]
Personalised Medicine in the People’s Republic of China is principally developed through the Five-Year Plans, that include [...]
IC2PerMed at a glance
Supporting International collaboration for the development of Personalised Medicine
The International Consortium for Personalised Medicine (ICPerMed), umbrella initiative of IC2PerMed, aims at initiating and supporting communication and exchange on Personalised Medicine (PM) for aligning national agendas on research and funding activities. It brings together representatives of funding agencies and authorities from 29 countries and expands for increasing PM developments’ synergies at international level.
IC2PerMed project’s core objective is to build upon collaborative developments of Chinese and European experts on PM for elaborating a common strategy, enabling Chinese institutions to join the ICPerMed consortium. The 3 Expert Working Groups will set the path for a common approach of PM research, innovation, development and implementation over the project duration.